Skip to Main Content

Author Details

Tina Primeau
2003
19
12
PMIDPaper TitleJournal TitlePublished Year
34996889Author Correction: Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidates for targeted treatment.Nat Commun2022
36395883Diptoindonesin G is a middle domain HSP90 modulator for cancer treatment.Journal of Biological Chemistry2022
34429404Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidatesfor targeted treatment.Nat Commun2021
33591953Chromosome 8 gain is associated with high-grade transformation in MPNST.JCI Insight2021
34011995Mismatch repair deficiency predicts response to HER2 blockade in HER2-negative breast cancer.Nature Communications2021
33355448Hyaluronan-Conjugated Carbon Quantum Dots for Bioimaging Use.ACS applied materials & interfaces2021
34902246Macrocyclic Inhibitors of HGF-Activating Serine Proteases Overcome Resistance to Receptor Tyrosine Kinase Inhibitors and Block Lung Cancer Progression.Journal of Medicinal Chemistry2021
33371187Proteomic Resistance Biomarkers for PI3K Inhibitor in Triple Negative Breast Cancer Patient-Derived Xenograft Models.Cancers (Basel)2020
31196969Regulated Phosphosignaling Associated with Breast Cancer Subtypes and Druggability.Mol Cell Proteomics2019
30518672Cooperative Effect of Oncogenic <i>MET</i> and <i>PIK3CA</i> in an HGF-Dominant Environment in Breast Cancer.Mol Cancer Ther2019
31074257Assessment of Copper Nanoclusters for Accurate in Vivo Tumor Imaging and Potential for Translation.ACS applied materials &amp; interfaces2019
31369274Folate Receptor α-Targeted Zr-M9346A Immuno-PET for Image-Guided Intervention with Mirvetuximab Soravtansine in Triple-Negative Breast Cancer.Molecular Pharmaceutics2019
29472518Mass Spectrometry-Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers.Cancer Res2018
28619968Breast Cancer Neoantigens Can Induce CD8<sup>+</sup> T-Cell Responses and Antitumor Immunity.Cancer Immunol Res2017
25991817Efficacy of SERD/SERM Hybrid-CDK4/6 Inhibitor Combinations in Models of Endocrine Therapy-Resistant Breast Cancer.Clin Cancer Res2015
19892989A single peptide-MHC complex positively selects a diverse and specific CD8 T cell repertoire.Science2009
16698321Mucopolysaccharidosis I cats mount a cytotoxic T lymphocyte response after neonatal gene therapy that can be blocked with CTLA4-Ig.Molecular Therapy2006
16106063Applications of major histocompatibility complex class I molecules expressed as single chains.Immunologic Research2005
12732632Enhanced immune presentation of a single-chain major histocompatibility complex class I molecule engineered to optimize linkage of a C-terminally extended peptide.Journal of Biological Chemistry2003
  • 1 - 19 of 19

Recommended Authors

Collaborators

Co-authored papers 15
Co-authored papers 8
Co-authored papers 5
Co-authored papers 5
McDonnell Genome Institute, Washington University School of Medicine
Co-authored papers 5
Co-authored papers 4
Co-authored papers 4
Washington University in St Louis
Co-authored papers 3
Washington University in St Louis
Co-authored papers 3
Washington University in St. Louis
Co-authored papers 3
Department of Biology at Brigham Young University
Co-authored papers 2
The University of Texas MD Anderson Cancer Center
Co-authored papers 2
Washington University in St Louis
Co-authored papers 2
Washington University in St Louis
Co-authored papers 2
Siteman Cancer Center, Washington University School of Medicine
Co-authored papers 2
Icahn School of Medicine at Mount Sinai
Co-authored papers 2
National Cancer Institute, National Institutes of Health
Co-authored papers 2
University of Texas MD Anderson Cancer Center
Co-authored papers 2
Baylor College of Medicine
Co-authored papers 2
Co-authored papers 2
Institute for Systems Genetics, NYU Grossman School of Medicine
Co-authored papers 2
Co-authored papers 2
Washington University in St Louis
Co-authored papers 2
Ellen and Ronald Caplan Cancer Center, The Wistar Institute
Co-authored papers 2
Frederick National Laboratory for Cancer Research, Inc.
Co-authored papers 2
Washington University School of Medicine
Co-authored papers 2
Broad Institute of MIT and Harvard
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2